Sanofi is a diversified global healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company offers a broad range of prescription medicines, and consumer healthcare and generic products worldwide. It operates its business in three broad categories, namely, Pharmaceuticals, Vaccines and Animal Health. The Pharmaceutical segment of the company focuses on the development of products in the areas of cardiovascular diseases, thrombosis, diabetes, central nervous system (CNS) disorders, general diseases such as benign prostatic hyperplasia, osteoporosis and rheumatoid arthritis, besides cancer. Sanofi offers vaccines such as pediatric combinations and poliomyelitis vaccines, influenza, adult and adolescent booster, meningitis, travel and endemic, and measles, mumps and rubella (MMR). The Animal Health segment provides an array of medicines and vaccines for a wide range of animal species. Sanofi is headquartered in Paris, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Sanofi - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Sanofi Company Snapshot 5 Sanofi Company Overview 5 Key Information 5 Sanofi Pipeline Products and Clinical Trials Overview 6 Sanofi – Pipeline Analysis Overview 8 Business Description 8 Key Facts 9 Sanofi - Major Products and Services 10 Sanofi Pipeline Products by Development Stage 12 Sanofi Clinical Trials by Trial Status 14 Sanofi Pipeline Products Overview 16 Fix-Flex Device 16 Fix-Flex Device Product Overview 16 Lumagel 17 Lumagel Product Overview 17 MACI 18 MACI Product Overview 18 MACI Clinical Trial 19 ST01 Bone Graft Substitute Material 20 ST01 Bone Graft Substitute Material Product Overview 20 ST03 Activated Implant 21 ST03 Activated Implant Product Overview 21 ST04 Activated Injectable 22 ST04 Activated Injectable Product Overview 22 ST05 23 ST05 Product Overview 23 Sanofi - Key Competitors 24 Sanofi - Key Employees 25 Sanofi - Key Employee Biographies 27 Sanofi - Locations And Subsidiaries 28 Head Office 28 Other Locations & Subsidiaries 28 Recent Developments 45 Sanofi, Recent Developments 45 Apr 15, 2014: Sanofi Launches Probi Digestis in Korea 45 Mar 31, 2014: Sanofi Appoints Dr. Anne C. Beal to the Newly Created Position of Chief Patient Officer 45 Mar 05, 2014: Sanofi’s Board of Directors Propose Appointment of Patrick Kron as New Independent Director 46 Feb 06, 2014: Sanofi Returns to Growth in Q4 2013 46 Jan 30, 2014: Sanofi Files Suit in The U.S. To Defend Its Patent Rights on Lantus and Lantus SoloStar 47 Jan 15, 2014: Sanofi and Fraunhofer announce the creation of a Natural Product Center of Excellence 47 Jan 09, 2014: Isarna Therapeutics Enters into a Strategic Manufacturing Agreement with Sanofi 48 Jan 02, 2014: Sanofi To Expand Access to Clinical Trial Data 48 Dec 20, 2013: Lieff Cabraser Announces Class Action Litigation Against Sanofi 48 Dec 20, 2013: Genzyme Corp. to Pay $22.28 Million to Resolve False Claims Allegations Related to “Slurry” Used in Patients 49 Appendix 51 Methodology 51 About GlobalData 51 Contact Us 51 Disclaimer 51 List of TablesList of Tables Sanofi, Key Facts 5 Sanofi Pipeline Products and Clinical Trials Overview 6 Sanofi Pipeline Products by Equipment Type 6 Sanofi Pipeline Products by Indication 7 Sanofi Clinical Trials by Trial Status 7 Sanofi, Key Facts 9 Sanofi, Major Products and Services 10 Sanofi Number of Pipeline Products by Development Stage 12 Sanofi Pipeline Products Summary by Development Stage 13 Sanofi Clinical Trials by Trial Status 14 Sanofi Clinical Trials Summary 15 Fix-Flex Device - Product Status 16 Fix-Flex Device - Product Description 16 Lumagel - Product Status 17 Lumagel - Product Description 17 MACI - Product Status 18 MACI - Product Description 18 MACI - An Extension Protocol for Patients Who Completed Genzyme-Sponsored Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study of Matrix-Induced Autologous Chondrocyte Implantation (MACI Implant) for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle Including the Trochlea 19 ST01 Bone Graft Substitute Material - Product Status 20 ST01 Bone Graft Substitute Material - Product Description 20 ST03 Activated Implant - Product Status 21 ST03 Activated Implant - Product Description 21 ST04 Activated Injectable - Product Status 22 ST04 Activated Injectable - Product Description 22 ST05 - Product Status 23 ST05 - Product Description 23 Sanofi, Key Employees 25 Sanofi, Key Employee Biographies 27 Sanofi, Other Locations 28 Sanofi, Subsidiaries 29 List of FiguresList of Figures Sanofi Pipeline Products by Equipment Type 6 Sanofi Pipeline Products by Development Stage 12 Sanofi Clinical Trials by Trial Status 14
The Global Dental Laboratory Handpieces Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Laboratory Handpieces market.
First, the report ...Read More
Now, Chinese regulations on medical devices are undergoing earthshaking changes. China’s new leaders have recognized that the regulations for supervision and administration of medical devices are fa ...Read More
Production, means the output of Advanced Wound Care Management
Revenue, means the sales value of Advanced Wound Care Management
This report studies Advanced Wound Care Management in Global mar ...Read More
Production, means the output of Aliphatic Isocyanates
Revenue, means the sales value of Aliphatic Isocyanates
This report studies three types of Aliphatic Isocyanates (HDI, IPDI and H12MDI) in ...Read More
the last several years, global market of BP Cuff developed rapidly, with an average growth rate of 6.52%. In 2016, global revenue of BP Cuff is nearly 985.5 Million USD; the actual production is abou ...Read More
In the last several years, Global market of Cancer Treatment Drugs developed rapidly, with an average growth rate of 8.56%. In 2015, Global revenue of Cancer Treatment Drugs is nearly 107 bil ...Read More
Enamel and ceramic pigments
Refined petroleum catalyst
Other products raw materials
Company(G ...Read More
This report studies the Coextruded Medical Tube market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top p ...Read More
2017-2022 Global Hematology Analyzer Consumption Market Report is a professional and in-depth study on the current state of the Hematology Analyzer market.
First, the report provides a basic overview ...Read More
This report studies sales (consumption) of Neurobiology ELISA Kits in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, p ...Read More
Published By : GlobalData
For support please contact: US Toll Free
+1 888-789-6604 Asia Pacific
To receive alerts about an update, future offers and discounts on this report, signup here. Email ID